Product

XS005 Sorafenib

Aliases

Regimen B, Regimen C

1 clinical trial

2 indications

Indication

pharmacokinetics

Indication

Bioavailability

Clinical trial

A Single Part, Open-Label, Randomised, Three-Way Crossover Study Designed to Evaluate the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib From Sorafenib (XS005) Tablets and Capsules Compared With Nexavar® (Reference Product) in Healthy Male Subjects

Status: Completed, Estimated PCD: 2019-02-12